 CARLSBAD, Calif., June 14, 2022 GLOBE NEWSWIRE -- Qualigen Therapeutics, Inc. Nasdaq: QLGN, a diversified life sciences company focused on developing treatments for adult and pediatric cancers with potential for Orphan Drug Designation, while also commercializing diagnostics, today announces that Qualigen Therapeutics will present a corporate overview at the BIO International Convention to be held on June 13 16, 2022 at the San Diego Convention Center. 